Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol, sodium salt and palmitic acid

EU orphan designation number: EU/3/11/927   
Active ingredient: Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol, sodium salt and palmitic acid
Indication: Treatment of cystic fibrosis
Sponsor: Pharm Research Associates (UK) Limited
500 South Oak Way, Green Park, Reading, Berkshire RG2 6AD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/10/2011 Orphan designation EMA/OD/032/11 (2011)7904 of 27/10/2011
23/09/2015 Change of name and/or address of sponsor